DE69332520D1 - Nukleinsäure, expressionsvektor und zusammensetzungen zur identifizierung und herstellung von rekombinanten sialyltransferasen - Google Patents

Nukleinsäure, expressionsvektor und zusammensetzungen zur identifizierung und herstellung von rekombinanten sialyltransferasen

Info

Publication number
DE69332520D1
DE69332520D1 DE69332520T DE69332520T DE69332520D1 DE 69332520 D1 DE69332520 D1 DE 69332520D1 DE 69332520 T DE69332520 T DE 69332520T DE 69332520 T DE69332520 T DE 69332520T DE 69332520 D1 DE69332520 D1 DE 69332520D1
Authority
DE
Germany
Prior art keywords
recombinant
compositions
identification
preparation
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69332520T
Other languages
English (en)
Other versions
DE69332520T2 (de
Inventor
James C Paulson
Xiaohong Wen
Brian Livingston
William Gillespie
Sorge Kelm
Alma L Burlingame
Katalin Medzihradszky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
University of California
Original Assignee
University of California
Cytel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, Cytel Corp filed Critical University of California
Application granted granted Critical
Publication of DE69332520D1 publication Critical patent/DE69332520D1/de
Publication of DE69332520T2 publication Critical patent/DE69332520T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Ceramic Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69332520T 1992-03-09 1993-03-09 Nukleinsäure, expressionsvektor und zusammensetzungen zur identifizierung und herstellung von rekombinanten sialyltransferasen Expired - Lifetime DE69332520T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85035792A 1992-03-09 1992-03-09
US92536992A 1992-08-04 1992-08-04
PCT/US1993/002002 WO1993018157A1 (en) 1992-03-09 1993-03-09 Compositions and methods for the identification and synthesis of sialyltransferases

Publications (2)

Publication Number Publication Date
DE69332520D1 true DE69332520D1 (de) 2003-01-09
DE69332520T2 DE69332520T2 (de) 2003-09-11

Family

ID=27126928

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69332520T Expired - Lifetime DE69332520T2 (de) 1992-03-09 1993-03-09 Nukleinsäure, expressionsvektor und zusammensetzungen zur identifizierung und herstellung von rekombinanten sialyltransferasen

Country Status (17)

Country Link
EP (1) EP0632831B1 (de)
JP (1) JPH07505771A (de)
KR (1) KR100300467B1 (de)
AT (1) ATE228565T1 (de)
AU (1) AU668714B2 (de)
BG (1) BG62492B1 (de)
CA (1) CA2131703C (de)
CZ (1) CZ220494A3 (de)
DE (1) DE69332520T2 (de)
DK (1) DK0632831T3 (de)
ES (1) ES2191011T3 (de)
FI (1) FI119692B (de)
HU (1) HU219260B (de)
NO (1) NO314666B1 (de)
NZ (1) NZ251096A (de)
SK (1) SK108894A3 (de)
WO (1) WO1993018157A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5384249A (en) * 1991-12-17 1995-01-24 Kyowa Hakko Kogyo Co., Ltd. α2→3 sialyltransferase
US5849904A (en) * 1994-12-22 1998-12-15 Boehringer Mannheim Gmbh Isolated nucleic acid molecules which hybridize to polysialyl transferases
AU692355B2 (en) * 1994-12-22 1998-06-04 Boehringer Mannheim Gmbh Isolated polysialyl transferases, nucleic acid molecules coding therefor, methods of production and use
AUPN658795A0 (en) * 1995-11-15 1995-12-07 Commonwealth Scientific And Industrial Research Organisation Method of producing alpha 2, 3 sialyltransferase
US6355255B1 (en) * 1998-12-07 2002-03-12 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
CA2320517A1 (en) * 1998-02-12 1999-08-19 Aventis Research & Technologies Gmbh & Co. Kg Expression vector for the production of dead proteins
US6194178B1 (en) 1998-09-03 2001-02-27 Synsorb Biotech Inc. Method for the production of sialylated oligosaccharides
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
JP4674702B2 (ja) 2003-04-09 2011-04-20 バイオジェネリクス エージー グリコペギレ−ション法およびその方法により生成されたタンパク質／ペプチド
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
EP1771066A2 (de) 2004-07-13 2007-04-11 Neose Technologies, Inc. Remodellierung von verzweigtem peg und klykolysierung von glucagonähnlichem peptide-1 glp-1
KR101324681B1 (ko) 2004-07-21 2013-11-04 세이가가쿠 고교 가부시키가이샤 아스파라긴 결합형 당쇄 수식을 받지않은 변이형 당단백질
HUE026826T2 (en) 2004-10-29 2016-07-28 Ratiopharm Gmbh Modeling and glycopegylation of fibroblast growth factor (FGF)
JP4951527B2 (ja) 2005-01-10 2012-06-13 バイオジェネリックス アーゲー 糖ｐｅｇ化顆粒球コロニー刺激因子
US20070154992A1 (en) 2005-04-08 2007-07-05 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
CN101516388B (zh) 2006-07-21 2012-10-31 诺和诺德公司 通过o-联糖基化序列的肽的糖基化
JP2010505874A (ja) 2006-10-03 2010-02-25 ノヴォ ノルディスク アー／エス ポリペプチドコンジュゲートの精製方法
ES2406267T3 (es) 2007-04-03 2013-06-06 Biogenerix Ag Métodos de tratamiento usando G-CSF glicopegilado
MX2009013259A (es) 2007-06-12 2010-01-25 Novo Nordisk As Proceso mejorado para la produccion de azucares de nucleotidos.
AU2009219232B2 (en) 2008-02-27 2014-02-27 Novo Nordisk A/S Conjugated Factor VIII molecules
AU2009313615B2 (en) 2008-11-05 2012-11-29 Regents Of The University Of Minnesota Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease
WO2019147623A2 (en) * 2018-01-23 2019-08-01 Virginia Commonwealth University Mda-7/il secretory variants and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059535A (en) * 1989-04-12 1991-10-22 Chembiomed, Ltd. Process for the separation and purification of sialyl transferases
US5032519A (en) * 1989-10-24 1991-07-16 The Regents Of The Univ. Of California Method for producing secretable glycosyltransferases and other Golgi processing enzymes
DE4028800A1 (de) * 1990-09-11 1992-03-12 Behringwerke Ag Gentechnische sialylierung von glykoproteinen
SE9201544L (sv) * 1991-05-31 1992-12-01 Ciba Geigy Ag Saett att framstaella glykosyltransferaser
GB2256197B (en) * 1991-05-31 1995-11-22 Ciba Geigy Ag Yeast as host for expression of heterologous glycosyl transferase enzymes

Also Published As

Publication number Publication date
FI944136A (fi) 1994-11-08
JPH07505771A (ja) 1995-06-29
HUT69933A (en) 1995-09-28
NZ251096A (en) 1996-03-26
CZ220494A3 (en) 1995-03-15
AU3791993A (en) 1993-10-05
DE69332520T2 (de) 2003-09-11
HU219260B (en) 2001-03-28
FI944136A0 (fi) 1994-09-08
HU9402586D0 (en) 1994-11-28
AU668714B2 (en) 1996-05-16
ATE228565T1 (de) 2002-12-15
WO1993018157A1 (en) 1993-09-16
NO943323D0 (no) 1994-09-08
NO314666B1 (no) 2003-04-28
NO943323L (no) 1994-11-01
DK0632831T3 (da) 2003-03-24
EP0632831B1 (de) 2002-11-27
CA2131703A1 (en) 1993-09-16
SK108894A3 (en) 1995-07-11
ES2191011T3 (es) 2003-09-01
BG99100A (bg) 1995-05-31
KR100300467B1 (de) 2001-10-22
CA2131703C (en) 2007-08-21
BG62492B1 (bg) 1999-12-30
FI119692B (fi) 2009-02-13
EP0632831A1 (de) 1995-01-11

Similar Documents

Publication Publication Date Title
DE69332520D1 (de) Nukleinsäure, expressionsvektor und zusammensetzungen zur identifizierung und herstellung von rekombinanten sialyltransferasen
NO179253C (no) Rekombinant DNA-sekvens som koder for humant proapolipoprotein A-I, ekspresjonsvektorer, cellekulturer samt fremgangsmåte for fremstilling av proteinet
HUT67683A (en) Dna sequences encoding novel growth/differentiation factors
DK0817846T3 (da) Intracellulært domæne af HER-2/neu proteinet til forebyggelse eller behandling af maligniteter
HUT71847A (en) Dna molecules encoding aminopeptidase enzymes, vectors and transgenic cells containing dna molecules, immunogenic polypeptides encoding by dna molecules, vaccines against helminth infections containing these peptides and process for the preparation ...
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
GB9215232D0 (en) Vaccines
KR950700415A (ko) 말라리아 백신(improvements in or relating to malaria vaccine)
DE69031996T2 (de) Menschlicher rekombinanter plazentaler ribonuklease-inhibitor und verfahren zur herstellung
ATE83800T1 (de) Rekombinantes dns-plasmid zur herstellung von xanthangummi.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NEOSE TECHNOLOGIES, INC., HORSHAM, PA., US

Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, O, US

8327 Change in the person/name/address of the patent owner

Owner name: NOVO NORDISK A/S, BAGSVAERD, DK

Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, O, US